A safety analysis of thromboprophylaxis in acute medical illness

Thrombosis and Haemostasis

Volumn 89, Issue 3, 2003, Pages 590-591

  Alikhan, Raza ^a   Cohen, Alexander T ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEMOGLOBIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ACUTE DISEASE; ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ACUTE RESPIRATORY FAILURE; BLEEDING; BLOOD TRANSFUSION; CLINICAL TRIAL; DEATH; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; ECHOGRAPHY; FATALITY; HEART FAILURE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION; INFLAMMATORY DISEASE; LETTER; LOW DRUG DOSE; LUNG EMBOLISM; META ANALYSIS; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RHEUMATIC DISEASE; RISK FACTOR; STROKE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT OUTCOME; TREATMENT PLANNING; VEIN THROMBOSIS;

EID: 0037338913     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613391     Document Type: Letter

References (11)

1. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA et al. Prevention of venous thromboembolism. Chest 2001; 119: 132S-75S.
2. Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R et al. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 2001; 20: 1-37.
3. Cohen A, Alikhan R. Prophylaxis of venous thromboembolism in medical patients. Current Opinion in Pulmonary Medicine 2001; 7: 332-7.
4. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: Are we detecting enough deep vein thrombosis? J R Soc Med 1989; 82: 203-5.
5. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
6. Mismetti P, Laporte-Simitsidis S, Tardy B, Cucherat M, Buchmuller A, Juillard-Delsart D et al. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: A meta-analysis of randomised clinical trials. Thromb Haemost 2000; 83: 14-9.
7. Offord R. Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients. Pharm World Sci. 2002 [In Press].
8. Alikhan R, et al. Use of thromboprophylaxis in nonsurgical patients: Survey of a London teaching hospital. Blood 2001; 98: 1142 (abtract).
9. Kleber FX, Witt C, Flosbach Cw, Koppenhagen K, the PRINCE Study Group. Comparison of the low molecular weight heparin enoxaparin with unfractionated heparin in the prevention of Venous Thromboembolic Events in Medical Patients with Severe Cardiopulmonary Disease. Thromb Haemost 1999; 82: 1552 (abstract).
10. Alikhan R, Vaughan P, Wilmott R, Osborne I, Gardner J, et al. Prevention of venous thromboembolism in medical patients: A meta-analysis of the clinical trials. Br J Haematol 2002; 117 (Suppl. 1): 23 (abstract 64).
11. Lechler E, Schramm W, Flosbach CW. The venous thrombotic risk in non-surgical patients: Epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study Group. Haemostasis 1996; 26 Suppl 2: 49-56.